Steward Partners Investment Advisory’s ImmunoCellular Therapeutics, Ltd. IMUC Stock Holding History

Steward Partners Investment Advisory’s Portfolio IMUC Stock Details IMUC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-125	Closed	–	–	2627
2018 Q3	$0	Buy	+125	New	+$29	﹤0.01%	2825

Other funds holding IMUC

Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

Steward Partners Investment Advisory's IMUC Position: Q4 2018 in Review

Steward Partners Investment Advisory sold out of ImmunoCellular Therapeutics, Ltd. (IMUC) in Q4 2018, closing a stake of 125 shares.

Steward Partners Investment Advisory first reported a position in IMUC in Q3 2018 and held it in 1 quarter. The position peaked at $0 in Q3 2018. 3 funds tracked by Wall St. Rank hold IMUC as of Q4 2018.

Steward Partners Investment Advisory reported no remaining ImmunoCellular Therapeutics, Ltd. position as of Q4 2018 after selling out during the quarter.
Steward Partners Investment Advisory sold 125 ImmunoCellular Therapeutics, Ltd. shares in Q4 2018.
Steward Partners Investment Advisory first reported a position in ImmunoCellular Therapeutics, Ltd. in Q3 2018 and held it in 1 quarter.
Steward Partners Investment Advisory's ImmunoCellular Therapeutics, Ltd. position peaked at $0 in Q3 2018.
3 funds tracked by Wall St. Rank held ImmunoCellular Therapeutics, Ltd. as of Q4 2018.

Based on Steward Partners Investment Advisory's 13F filing for Q4 2018, filed 15 Jan 2019.